Beyond the RAAS: dissecting the antifibrotic effects of vitamin D analogues

Lab Invest. 2012 Dec;92(12):1666-9. doi: 10.1038/labinvest.2012.150.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / metabolism
  • Animals
  • Fibrosis
  • Humans
  • Kidney / pathology
  • Mice
  • Mice, Knockout
  • Protective Agents / pharmacology
  • Renal Insufficiency, Chronic / drug therapy*
  • Renal Insufficiency, Chronic / metabolism
  • Renal Insufficiency, Chronic / pathology
  • Renin-Angiotensin System / drug effects
  • Vitamin D / analogs & derivatives*
  • Vitamin D / pharmacology

Substances

  • Protective Agents
  • Angiotensin II
  • Vitamin D